Has Christine Glenn, DO received payments from drug or device companies?

Yes. Drug and device makers reported $58,233 in general payments to Christine Glenn, DO across 96 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christine Glenn, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christine Glenn, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christine Glenn, DO

Psychiatry · Kansas City, KSNPI 1629497391

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $46,220 of the $58,233 with a category attached, or 79.4%. Alkermes, Inc. accounts for 95.7% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $56,756, more than ten times the $712 reported in 2019. Among psychiatry clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$58,233in general payments, 2019–2025

Across 96 payments — averaging $606.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$56K
E.r. Squibb & Sons, L.L.C.$2K
Johnson & Johnson$380
Tris Pharma Inc$111
Otsuka America Pharmaceutical, Inc.$63
Shire North American Group Inc$52
plus $221 from 9 others

What the payments were for

Consulting fees$9,07016%
Speaking & faculty fees$46,22079%
Travel & lodging$5371%
Food & beverage$2,4064%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	59	$55,747
E.r. Squibb & Sons, L.L.C.	2	$1,659
Johnson & Johnson	9	$380
Tris Pharma Inc	1	$111
Otsuka America Pharmaceutical, Inc.	4	$63
Shire North American Group Inc	4	$52
AbbVie	3	$39
Takeda Pharmaceuticals U.S.A., Inc.	4	$38
Lundbeck LLC	2	$31
Teva Pharmaceuticals USA, Inc.	2	$28
Vertical Pharmaceuticals, LLC	2	$28
Neurocrine Biosciences, Inc.	1	$18
Arbor Pharmaceuticals, Inc.	1	$14
Avanir Pharmaceuticals, Inc.	1	$14
Ironshore Pharmaceuticals Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$58,233 in reported general payments places this provider in the 95th percentile of 259 psychiatry providers in Kansas.

See all psychiatry providers in Kansas →

Medicare billing

Part B allowed, 2024

$40,756

Medicare patients

132

Services billed

480

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	34	$1,842
Venlafaxine Hcl ErVenlafaxine Hcl	50	$1,509
Hydroxyzine Hcl	49	$820
Mirtazapine	49	$795
Vilazodone Hcl	12	$727
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	14	$609
Buspirone Hcl	17	$476
Clonazepam	46	$449
Trazodone Hcl	69	$444
Bupropion XlBupropion Hcl	19	$432
Quetiapine Fumarate	29	$414
Gabapentin	26	$274
Lorazepam	23	$211
Fluoxetine Hcl	40	$199
Escitalopram Oxalate	17	$155

Paid to pharmacies, not to this prescriber.

Other psychiatry in Kansas City

Dennis OwensKansas City$11K
Gregory PrierKansas City$3K
Ann GenoveseKansas City$3K
Jennifer HansonKansas City$3K
Navneet HundalKansas City$2K
David WichmanManhattan$613K
Kevin MaysLeawood$548K
Sheldon PreskornWichita$498K
James OwensSalina$433K
Sasha HamdaniOverland Park$104K

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →